Story perspectives

22 Children Dead from Contaminated Cough Syrup Crisis

10/16/2025

Summary

Story summary

The deaths of at least 22 children from diethylene glycol–contaminated cough syrup Coldrif, produced by Sresan Pharmaceuticals, signal a public health crisis.
Investigations reveal poor manufacturing conditions and a fractured regulatory framework, with authorities failing to coordinate.
In response, the government plans to introduce the Drugs, Medical Devices, and Cosmetics Act 2025 to strengthen oversight.
Despite these efforts, past incidents raise concerns about safety and public trust in the industry.

History

Historical Context

The Elixir Sulfanilamide tragedy in 1937, which resulted in over 100 deaths due to toxic diethylene glycol, prompted Congress to enact the Federal Food, Drug, and Cosmetic Act in 1938. This legislation established rigorous drug safety regulations, requiring manufacturers to conduct safety tests. Recent incidents of contaminated cough syrup underscore ongoing challenges in public health oversight and the need for stronger regulations, such as the proposed Drugs, Medical Devices, and Cosmetics Act 2025.

1 of 2

Story summary

The deaths of at least 22 children from diethylene glycol–contaminated cough syrup Coldrif, produced by Sresan Pharmaceuticals, signal a public health crisis.
Investigations reveal poor manufacturing conditions and a fractured regulatory framework, with authorities failing to coordinate.
In response, the government plans to introduce the Drugs, Medical Devices, and Cosmetics Act 2025 to strengthen oversight.
Despite these efforts, past incidents raise concerns about safety and public trust in the industry.

1 / 2